Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Carcinogenesis

• Publication date

  2014-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/carcin/bgu136PMID 24947179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

  2014cited by this paper
• KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.

  2013cited by this paper
• Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.

  2013cited by this paper
• Pancreatic cancer.

  2013cited by this paper
• Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.

  2013cited by this paper
• Histone Demethylase KDM6B Promotes Epithelial-Mesenchymal Transition*

  2012cited by this paper
• EZH2 couples pancreatic regeneration to neoplastic progression.

  2012cited by this paper
• EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

  2012cited by this paper
• Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.

  2012cited by this paper
• Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization

  2012cited by this paper
• Expression and significance of histone H3K27 demethylases in renal cell carcinoma

  2012cited by this paper
• Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence.

  2011cited by this paper
• Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes

  2011cited by this paper
• The H3K27me3 demethylase, KDM6B, is induced by Epstein–Barr virus and over-expressed in Hodgkin's Lymphoma

  2011cited by this paper
• Pancreatic cancer.

  2010cited by this paper
• C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.

  2010cited by this paper
• Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers

  2010cited by this paper
• Phenotype and Genotype of Pancreatic Cancer Cell Lines

  2010cited by this paper
• Deregulation of H3K27 methylation in cancer

  2010cited by this paper
• Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.

  2009cited by this paper
• Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.

  2009influential reference
• In prostate cancer C/EBPα promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT

  2009cited by this paper
• Epigenetic regulation and molecular characterization of C/EBPα in pancreatic cancer cells

  2009cited by this paper
• Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

  2009cited by this paper
• The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence.

  2009influential reference
• Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease.

  2008cited by this paper
• Activation of CCAAT/Enhancer‐Binding Protein α or PU.1 in Hematopoietic Stem Cells Leads to Their Reduced Self‐Renewal and Proliferation

  2008cited by this paper
• Integrated Analysis of Copy Number Alterations and Loss of Heterozygosity in Human Pancreatic Cancer Using a High-Resolution, Single Nucleotide Polymorphism Array

  2008cited by this paper
• UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development

  2007cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• JMJD3 is a histone H3K27 demethylase

  2007cited by this paper
• Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.

  2006cited by this paper
• Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.

  2006cited by this paper
• Control of developmental regulators by Polycomb in human embryonic stem cells.

  2006cited by this paper
• Down-Regulation and Growth Inhibitory Role of C/EBPα in Breast Cancer

  2005cited by this paper
• Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

  2005cited by this paper
• Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia.

  2005cited by this paper
• Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha.

  2004cited by this paper
• Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

  2003influential reference
• Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

  2003cited by this paper
• Down-regulation and antiproliferative role of C/EBPalpha in lung cancer.

  2002cited by this paper
• Down-Regulation and Antiproliferative Role of C/EBPα in Lung Cancer

  2002cited by this paper
• Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.

  2002influential reference
• Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

  2001cited by this paper
• Progression model for pancreatic cancer.

  2000cited by this paper
• Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.

  1998cited by this paper
• Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein.

  1996cited by this paper
• Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

  1994cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Chromatin Modifications and Their Function

  year unknowncited by this paper

• Structural landscape of H3K27me3 recognition by protein domains and their potential for inhibition.

  2026cites this paper
• Signaling pathways and targeted interventions for precancers

  2026cites this paper
• A review of C/EBP α: a potential novel target for solid tumor intervention

  2025cites this paper
• Lysine demethylase 6 (KDM6): A promising therapeutic target in autoimmune disorders and cancer.

  2025cites this paper
• Navigating the Paradox of Senescence and Chemoresistance in Pancreatic Cancer.

  2025cites this paper
• Precision peptide disruptors: The next generation of targeted therapeutics in oncology.

  2025cites this paper
• Roles of Kdm6a and Kdm6b in Regulation of Mammalian Neural Regeneration

  2025cites this paper
• BIX01294 suppresses PDAC growth through inhibition of glutaminase-mediated glutathione dynamics

  2025cites this paper
• EZH2 Dysregulation and Its Oncogenic Role in Human Cancers

  2025cites this paper
• KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma

  2024cites this paper
• 2-oxoglutarate-dependent Dioxygenases (2-OGDDs) as Oxygen Sensors: Their Importance in Health and Disease.

  2024cites this paper
• Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer

  2024cites this paper
• Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer

  2024cites this paper
• Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer decorated tetrahedral framework nucleic acid

  2024cites this paper
• Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma

  2024cites this paper
• Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex

  2024cites this paper
• E2F1-driven histone demethylase KDM6B enhances thyroid malignancy via manipulating TFEB-dependent autophagy axis.

  2023cites this paper
• Exosome and lipid metabolism-related genes in pancreatic adenocarcinoma: a prognosis analysis

  2023cites this paper
• Loss of KDM6B epigenetically confers resistance to lipotoxicity in nonalcoholic fatty liver disease–related HCC

  2023cites this paper
• Context-Dependent Functions of KDM6 Lysine Demethylases in Physiology and Disease.

  2023cites this paper
• β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy

  2023cites this paper
• Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia

  2023cites this paper
• Downregulation of the endothelial histone demethylase JMJD3 is associated with neointimal hyperplasia of arteriovenous fistulas in kidney failure

  2022cites this paper
• An Overview of Epigenetic Methylation in Pancreatic Cancer Progression

  2022cites this paper
• JMJD3 suppresses tumor progression in oral tongue squamous cell carcinoma patients receiving surgical resection

  2022cites this paper
• Emerging roles of JMJD3 in cancer

  2022cites this paper
• circRNA circ_102049 Implicates in Pancreatic Ductal Adenocarcinoma Progression through Activating CD80 by Targeting miR-455-3p

  2021cites this paper
• KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer

  2021cites this paper
• KDM6 Demethylases and Their Roles in Human Cancers

  2021cites this paper
• Histone methylation in pancreatic cancer and its clinical implications

  2021cites this paper
• Prognostic Significance of JMJD3 Expression in Pleural Mesotheliomas

  2021cites this paper
• Investigation of Aberrantly Methylated Differentially Expressed Genes in Pancreatic Cancer by Integrated Bioinformatics Analysis

  2021cites this paper
• Histone demethylase KDM6B inhibits breast cancer metastasis by regulating Wnt/β‐catenin signaling

  2021cites this paper
• Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers

  2021cites this paper
• Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma

  2021cites this paper
• Epigenetic regulation of TGF-β-induced EMT by JMJD3/KDM6B histone H3K27 demethylase

  2021cites this paper
• KDM6B (JMJD3) and its dual role in cancer.

  2021cites this paper
• KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer

  2021cites this paper
• Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities

  2020cites this paper
• Prognostic prediction of a 12-methylation gene-based risk score system on pancreatic adenocarcinoma

  2020cites this paper
• KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma

  2020cites this paper
• The role of histone methylation in the development of digestive cancers: a potential direction for cancer management

  2020cites this paper
• 2-Oxoglutarate-dependent dioxygenases in cancer

  2020cites this paper
• Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis

  2020cites this paper
• Histone demethylase inhibitors and their potential in cancer treatment

  2020cites this paper
• Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer

  2020cites this paper
• KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription

  2020cites this paper
• Long noncoding RNA ARHGAP27P1 inhibits gastric cancer cell proliferation and cell cycle progression through epigenetically regulating p15 and p16

  2019cites this paper
• A novel KDM5A/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism

  2019cites this paper
• The role and prospect of JMJD3 in stem cells and cancer.

  2019cites this paper
• Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC

  2019cites this paper
• The diagnostic performance of lysine(K)-specific demethylase 6B (KDM6B) in non-small cell lung cancer

  2019cites this paper
• Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance

  2019cites this paper
• Roles of H 3 K 27 me 3 Demethylase JMJD 3 in Inflammation and Cancers

  2019cites this paper
• JMJD3 expression is an independent prognosticator in patients with esophageal squamous cell carcinoma☆

  2019cites this paper
• Targeting the Epigenome as a Therapeutic Strategy for Pancreatic Tumors: DNA and Histone Modifying Enzymes

  2019cites this paper
• Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2

  2018influential citation
• Dual prognostic role for 2-oxoglutarate oxygenases in ten diverse cancer types: Implications for cell cycle regulation and cell adhesion maintenance

  2018cites this paper
• Pathway maps enable straightforward yet customized and semi-automated yet insightful analyses of omics data

  2018cites this paper
• An Ensemble Framework Coping with Instability in the Gene Selection Process

  2018cites this paper
• An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma

  2018cites this paper
• Loss of CCAAT‐enhancer‐binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

  2018cites this paper
• Aptamer-iRNAs as Therapeutics for Cancer Treatment

  2018influential citation
• KDM6B promotes ovarian cancer cell migration and invasion by induced transforming growth factor‐β1 expression

  2018cites this paper
• JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML

  2018cites this paper
• E47 Governs the MYC-CDKN1B/p27KIP1-RB Network to Growth Arrest PDA Cells Independent of CDKN2A/p16INK4A and Wild-Type p53

  2018cites this paper
• Lysine methylation signaling in pancreatic cancer

  2018cites this paper
• Therapeutic Potential of small Activating RNAs (saRNAs) in Human Cancers

  2018cites this paper
• JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing β-MHC expression.

  2018cites this paper
• Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B

  2018cites this paper
• Targeting Epigenetic Modifiers for Cancer Treatments

  2018cites this paper
• Current Advances in Aptamers for Cancer Diagnosis and Therapy

  2018cites this paper
• Kdm6b is Required for Self-Renewal of Normal and Leukemic Mouse Stem Cells Under Proliferative Stress

  2018cites this paper
• Treatment of Pancreatic Cancer by Aptamer Conjugated C/EBPα-saRNA.

  2017cites this paper
• Lysine-Specific Histone Demethylases Contribute to Cellular Differentiation and Carcinogenesis

  2017cites this paper
• Emerging cancer-specific therapeutic aptamers

  2017cites this paper
• Marked for death: targeting epigenetic changes in cancer

  2017cites this paper
• Epigenetic gene regulation by histone demethylases: emerging role in oncogenesis and inflammation.

  2017cites this paper
• Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs

  2017cites this paper
• Challenging cancer targets for aptamer delivery.

  2017cites this paper
• MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer

  2017cites this paper
• Orchestration of H3K27 methylation: mechanisms and therapeutic implication

  2017cites this paper
• Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing

  2017cites this paper
• Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation

  2017cites this paper
• The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future Perspectives.

  2016cites this paper
• C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT

  2016cites this paper
• The Prognostic Significance of Histone Lysine Demethylase JMJD3/KDM6B in Colorectal Cancer

  2016cites this paper
• A New Chromatin–Cytoskeleton Link in Cancer

  2016cites this paper
• Crosstalk Between DNA Methylation and Chromatin Structure

  2016cites this paper
• Epigenome modifying enzymes regulate development and progression of pancreatic cancers

  2016cites this paper
• Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

  2016cites this paper
• Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo

  2016cites this paper
• Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer

  2016cites this paper
• H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis.

  2016cites this paper
• The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure.

  2015cites this paper
• JMJD3 as an epigenetic regulator in development and disease.

  2015cites this paper
• Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma

  2015cites this paper
• KDM6B Elicits Cell Apoptosis by Promoting Nuclear Translocation of FOXO1 in Non-Small Cell Lung Cancer

  2015cites this paper